Hepatitis in clinical practice

References

• Robinson WS. Non-A. non-B hepatitis. In: Hoeprich PD. ed. Infectious diseases: a modem treatise of Infectious process. 3d ed. New York: Harper & Row, 1983: 729–32
   Google Scholar
• Robinson WS. Non-A. non-B hepatitis. In: Mandell GL, Douglas RG. Bennett JE, eds. Principles and practice of infectious diseases. 2d ed. New York: J Wiley, 1985: 1029–33
   Google Scholar
• Miller DJ. Seroepidemiology of viral hepatitis: correlation with clinical findings. Postgrad Med 1980: 68(3): 137–48
   PubMed Web of Science ®Google Scholar
• Achord JL. Non-A. non-B hepatitis: similarities to hepatitis A and B. Consultant 1981: 21(Jan): 204–16
   Google Scholar
• Mann JA, Hays RA. Severe liver disease years after car crash. Hosp Pract (Off) 1984: 19(1): 55–65
   PubMed Web of Science ®Google Scholar
• Bryan JA. Viral hepatitis. 1. Clinical and laboratory aspects and epidemiology. Postgrad Med 1980: 68(5): 66–76
   PubMed Web of Science ®Google Scholar
• Kane MA. Bradley DW, Shrestha SM. et al. Epidemic non-A, non-B hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984: 252(22): 3140–5
   PubMed Web of Science ®Google Scholar
• Seto B, Coleman WG Jr, Iwarson S, et al. Detection of reverse transcriptase activity in association with the non-A. non-B hepatitis agent(s). Lancet 1984: 2(8409): 941–3
   PubMed Web of Science ®Google Scholar
• Francis DP, Hadler SC, Prendergast TJ, et al. Occurrence of hepatitis A. B. and non-A/non-B In the United States: CDC Sentinel County hepatitis study 1. Am J Med 1984: 76(1): 69–74
   PubMed Web of Science ®Google Scholar
• Friedman LS, Wands JR. Non-A, non-B hepatitis. In: Petersdorf RG. Adams RD. Braunwald E. eds. Harrison's principles of internal medicine. Update V. New York: McGraw-Hill. 1984: 97–115
   Google Scholar
• Gilliam JH 3d, Geisinger KR, Richter JE. Primary hepatocellular carcinoma after chronic non-A. non-B post-transfusion hepatitis. Ann Intern Med 1984: 101(6): 794–5
   PubMed Web of Science ®Google Scholar
• Resnick RH, Stone K, Antonioli D. Primary hepatocellular carcinoma following non-A. non-B posttransfusion hepatitis. Dig Dis Sci 1983: 28(10): 908–11
   PubMed Web of Science ®Google Scholar
• Zeldis JB, Dienstag JL, Gale RP. Aplastic anemia and non-A. non-B hepatitis. Am J Med 1983: 74(1): 64–8
   PubMed Web of Science ®Google Scholar
• Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the transfusion-transmitted virus study. N Engl J Med 1981: 304(17): 989–94
   PubMed Web of Science ®Google Scholar
• Holland PV, Bancroft W, Zimmerman H. Post-transfusion viral hepatitis and the TTVS. (Editorial) N Engl J Med 1981: 304(17): 1033–5
   PubMed Web of Science ®Google Scholar
• Hornbrook MC, Dodd RY, Jacobs P, et al. Reducing the incidence of non-A, non-B post-transfusion hepatitis by testing donor blood for alanine aminotransferase: economic considerations. N Engl J Med 1982: 307(21): 1315–21
   PubMed Web of Science ®Google Scholar
• Silverstein MD, Mulley AG, Dienstag JL. Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis. JAMA 1984: 252(20): 2839–45
   PubMed Web of Science ®Google Scholar
• Stevens CE, Aach RD, Hollinger FB. et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A. non-B hepatitis In transfusion recipients: an analysis of the transfusion-transmitted viruses study. Ann Intern Med 1984: 101(6): 733–8
   PubMed Web of Science ®Google Scholar
• Alter HJ, Holland PV. Indirect tests to detect the non-A, non-B hepatitis carrier state. (Editorial) Ann Intern Med 1984: 101(6): 859–61
   PubMed Web of Science ®Google Scholar
• Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977: 18(12): 997–1003
   PubMed Web of Science ®Google Scholar
• Redeker AG. Delta agent and hepatitis B. Ann Intern Med 1983: 98(4): 542–3
   PubMed Web of Science ®Google Scholar
• Rizzetto M, Hoyer B, Canese MG, et al. Delta agent: association of delta antigen with hepatitis B surface antigen and RNA In serum of delta-infected chimpanzees. Proc Natl Acad Sci USA 1980: 77(10): 6124–8
   PubMed Web of Science ®Google Scholar
• Gerin J. Biology of the hepatitis delta virus. Proceedings of the 22d Annual Meeting of the Infectious Diseases Society of America. Washington, DC: 1984
   Google Scholar
• Smedile A, Farci P, Verme G, et al. Influence of delta infection on severity of hepatitis B. Lancet 1982: 2(8305): 945–7
   Google Scholar
• Hadler SC, De Monzon M, Ponzetto A, et al. Delta virus infection and severe hepatitis: an epidemic in the Yucpa Indians of Venezuela. Ann Intern Med 1984: 100(3): 339–44
   PubMed Web of Science ®Google Scholar
• Rizzetto M, Verme G, Recchia S, et al. Chronic hepatitis In carriers of hepatitis B surface antigen, with intrahepatic expression of delta antigen: an active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983: 98(4): 437–41
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Delta hepatitis—Massachusetts. MMWR 1984: 33(35): 493–4
   PubMedGoogle Scholar
• Govindarajan S, Hevia FJ, Peters RL. Prevalence of delta antigen/antibody in B-viral-associated hepatocellular carcinoma. Cancer 1984: 53(8): 1692–4
   PubMed Web of Science ®Google Scholar
• Raimondo G, Smedile A, Gallo L, et al. Multicentre study of prevalence of HBV-associated delta Infection and liver disease In drug-addicts. Lancet 1982: 1(8266): 249–51
   PubMed Web of Science ®Google Scholar
• Rizzetto M, Purcell RH, Gerin JL. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet 1980: 1(8180): 1215–8
   PubMed Web of Science ®Google Scholar
• Hansson BG, Moestrup T, Widell A, et al. Infection with delta agent In Sweden: introduction of a new hepatitis agent. J Infect Dis 1982: 146(4): 472–8
   PubMed Web of Science ®Google Scholar
• Jacobson IM, Dienstag JL, Werner BG, et al. Epidemiology and clinical Impact of hepatitis D virus (delta) infection. Hepatology 1985: 5(2): 188–91
   PubMed Web of Science ®Google Scholar
• Colombo M, Cambieri R, Rumi MG, et al. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology 1983: 85(2): 235–9
   PubMed Web of Science ®Google Scholar
• Kanel GC, Govindarajan S, Peters RL. Chronic delta Infection and liver biopsy changes In chronic active hepatitis B. Ann Intern Med 1984: 101(1): 51–4
   PubMed Web of Science ®Google Scholar
• Fanci P, Smedile A, Lavarini C, et al. Delta hepatitis in inapparent carriers of hepatitis B surface antigen: a disease simulating acute hepatitis B progressive to chronicity. Gastroenterology 1983: 85(3): 669–73
   PubMed Web of Science ®Google Scholar
• Smedile A, Dentico P, Zanetti A, et al. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology 1981: 81(6): 992–7
   PubMed Web of Science ®Google Scholar
• Moestrup T. Hansson BG, Widell A, et al. Clinical aspects of delta infection. Br Med J (Clin Res) 1983: 286(6359): 87–90
   PubMedGoogle Scholar
• Rizzetto M, Canese MG, Gerin JL, et al. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980: 141(5): 590–602
   PubMed Web of Science ®Google Scholar
• Govindarajan S, Chin KP, Redeker AG. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984: 86(6): 1417–20
   PubMed Web of Science ®Google Scholar
• Govindarajan S, Kanel GC, Peters RL. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology 1983: 85(1): 160–2
   PubMed Web of Science ®Google Scholar
• De Cock KM. Govindarajan S, Redeker AG. Acute delta hepatitis without circulating HBsAg. Gut 1985: 26(2): 212–4
   PubMed Web of Science ®Google Scholar
• Recchia S, Farci P, Smedile A, et al. Chronic delta hepatitis in carriers of the HBsAg: an active and progressive disease unresponsive to treatment. II Fegato 1982: 28(1): 35–8
   Google Scholar
• Nishioka NS, Dienstag JL. Delta hepatitis: a new scourge? (Editorial) N Engl J Med 1985: 312(23): 1515–6
   PubMed Web of Science ®Google Scholar
• Caredda F, Rossi E, D'Arminio Manforts A, et al. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis 1985: 151(5): 925–8
   PubMed Web of Science ®Google Scholar
• Farci P, Barbera C, Navone C, et al. Infection with delta agent in children. Gut 1985: 26(1): 4–7
   PubMed Web of Science ®Google Scholar
• Gmelin K, Roggendorf M, Schlipkoter U, et al. Delta Infection in a hemodialyzed patient. (Letter) J Infect Dis 1985: 151(2): 374
   PubMed Web of Science ®Google Scholar